Related Experiment Video
Updated: Aug 16, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Design issues in studies evaluating diagnostic tests for aspergillosis
Kieren A Marr1, Wendy Leisenring
1Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. kmarr@fhcrc.org
Abstract:
Although invasive aspergillosis is recognized as an increased concern for immunosuppressed patients, establishing an early diagnosis remains a challenge. Current methods for diagnosis, including sensitive radiography and invasive procedures to identify organisms in affected tissues, provide an early diagnosis for only a small proportion of patients infected with Aspergillus species. The availability of a standardized assay to detect circulating Aspergillus galactomannan, the BioRad Platelia Aspergillus galactomannan enzyme immunoassay, should be considered as a valuable tool. However, at present, clinical utility is hampered by controversies surrounding the performance of the test and an apparent lack of definitive data. These controversies emphasize the complexity inherent in analyzing diagnostic tests for aspergillosis. The widespread availability of a standardized assay may now allow us to address the multiple sources of variability and bias via large, cooperative studies.
Insights
Early diagnosis of invasive aspergillosis in immunocompromised patients is challenging. A standardized Aspergillus galactomannan assay shows promise, but requires further large-scale studies to resolve performance controversies.
Area of Science:
- Medical Mycology
- Clinical Diagnostics
- Immunocompromised Host Research
Background:
- Invasive aspergillosis poses a significant risk to immunosuppressed individuals.
- Current diagnostic methods, including radiography and tissue biopsy, have limited early detection capabilities for Aspergillus infections.
Purpose of the Study:
- To evaluate the clinical utility of a standardized assay for detecting circulating Aspergillus galactomannan.
- To address controversies and data gaps regarding the performance of diagnostic tests for invasive aspergillosis.
Main Methods:
- Review of current diagnostic challenges and the introduction of the BioRad Platelia Aspergillus galactomannan enzyme immunoassay.
- Discussion of the need for large, cooperative studies to overcome variability and bias in diagnostic test analysis.
Main Results:
- The BioRad Platelia Aspergillus galactomannan assay is a potentially valuable tool for detecting Aspergillus.
- Existing data and performance controversies hinder the definitive assessment of the assay's clinical utility.
Conclusions:
- Standardized assays for Aspergillus galactomannan offer a promising avenue for improved diagnosis.
- Further large-scale, cooperative studies are essential to validate diagnostic performance and resolve current controversies.
Related Concept Videos
Sputum Studies I: Gram Stain, cytology, and Acid-fast smear and culture
Gram Stain
The Gram Stain is an integral part of sputum studies. It involves the staining of sputum, which permits...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Pneumonia III: Complications and Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
